• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Merlin Biomed

edit

Merlin BioMed Group is a Registered Investment Advisor which invests globally in public healthcare companies. Founded in January, 1998, by Dr. Stuart T. Weisbrod, Merlin BioMed Group and its affiliates encompass several hedge funds.

Milestones

edit

• 
  Merlin Biomed invested in FibroGen. (2/16/05)
  Posted 6/30/10 at 11:25pm via fibrogen.com
• 
  Merlin Biomed invested in Genelabs Technologies. (6/27/06)
  Posted 4/23/10 at 9:30pm
• 
  Merlin Biomed invested in EUSA Pharma. (11/7/06)
  Posted 4/21/10 at 9:48pm
• 
  Merlin Biomed invested in RenaMed Biologics. (9/7/06)
  Posted 4/20/10 at 1:07am via venturecapitalreporter.com
• 
  Merlin Biomed invested in Gemin X Pharmaceuticals. (7/3/08)
  Posted 3/11/10 at 1:31am via siliconindia.com
• 
  Merlin Biomed invested in Metabolex. (4/19/07)
  Posted 11/9/09 at 3:58pm via Metabolex.com
• 
  Merlin Biomed invested in Metabolex. (11/5/09)
  Posted 11/9/09 at 3:52pm via Metabolex.com

Investments

Videos

Sources

1. Metabolex (Metabolex.com) [edit]
2. Gemin X Pharmaceuticals closes $38 Mn Series C financing (siliconindia.com) [edit]
3. Metabolex (Metabolex.com) [edit]
4. Cap Funding Report [edit]
5. RenaMed Biologics Secures $40 Million in Private Equity Financing (venturecapitalreporter.com) [edit]
6. Cap Funding Report [edit]
7. FIBROGEN COMPLETES EQUITY FINANCING (fibrogen.com) [edit]